Jason Bacharach MD

Ophthalmology•Petaluma, CA

Anterior Segment Related, Cataract Related, Glaucoma Related

Medical Director & Founding Partner North Bay Eye Associates, Inc.

Join to View Full Profile

104 Lynch Creek WaySuite 15Petaluma, CA 94954
Phone+1 707-762-3573
Fax+1 707-762-6873

Education & Training

Drexel University College of Medicine/Hahnemann University HospitalResidency, Ophthalmology, 1989 - 1992
Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 1988 - 1989
Drexel University College of MedicineClass of 1988

Certifications & Licensure

CA State Medical License 1992 - 2026
PA State Medical License 1990 - 1992
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) Start of enrollment: 2008 Jun 01
Completed
Phase 4
Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery Start of enrollment: 2011 Dec 22
Completed
Not Applicable
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery Start of enrollment: 2012 Jan 16
Completed
Not Applicable
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)
TERMINATED
Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain Start of enrollment: 2016 Jun 01
Completed
Phase 3
Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease Start of enrollment: 2021 Jan 07
COMPLETED
PHASE2
Join now to see all

Publications & Presentations

PubMed

Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study.
Tanner J Ferguson, Thomas W Samuelson, Leon Herndon, Daniel C Terveen, Jason Bacharach
American Journal of Ophthalmology. 2025-07-01
Double-Masked, Dose-Response, Vehicle-Controlled Study of VVN461 Ophthalmic Solution in Postoperative Ocular Inflammation.
James H Peace, Kevin Y Jong, Jason Bacharach, Xiao-Yan Li, Wang Shen
Ophthalmology Science. 2025-04-25
Early Effects of Perfluorohexyloctane Ophthalmic Solution on Patient-Reported Outcomes in Dry Eye Disease: A Prospective, Open-Label, Multicenter Study.
Jason Bacharach, Shane R Kannarr, Anthony Verachtert, Preeya K Gupta, Moataz Razeen
Ophthalmology and Therapy. 2025-04-01

Authored Content

Proper DropperJanuary 2024
Real-World Data Show Additive Effects of NetarsudilNovember 2020

Press Mentions

PolyActiva Announces First Patient Enrolled in US Phase 2b Clinical Trial of Its Ocular Micro Implant for Glaucoma and Ocular HypertensionAugust 6th, 2025
VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract SurgeryDecember 3rd, 2024
https://www.prnewswire.com/news-releases/Iyuzeh-Latanoprost-Ophthalmic-Solution-0-005-the-First-and-Only-Preservative-Free-Latanoprost-Ophthalmic-Solution-Demonstrated-Similar-Iop-Lowering-Efficacy-with-a-favorable-Safety-Profile-When-Compared-to-Xalatan-in-Patien-301761686.htmlMarch 3rd, 2023
Join now to see all

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow